Literature DB >> 28936010

Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.

Bridgette Martinak1, Ramy A Bolis1, Jeffrey Ryne Black1, Rachel E Fargason1, Badari Birur1.   

Abstract

Dextromethorphan (3-methoxy-N-methylmorphinan), also known as "DXM" and "the poor man's PCP," is a synthetically produced drug that is available in more than 140 over-the-counter cough and cold preparations. Dextromethorphan (DXM) has overtaken codeine as the most widely used cough suppressant due to its availability, efficacy, and safety profile at directed doses. However, DXM is subject to abuse. When consumed at inappropriately high doses (over 1500 mg/day), DXM can induce a state of psychosis characterized by Phencyclidine (PCP)-like psychological symptoms, including delusions, hallucinations, and paranoia. We report a noteworthy case of severe dextromethorphan use disorder with dextromethorphan-induced psychotic disorder in a 40-year-old Caucasian female, whose symptoms remitted only following treatment with a combination of an antipsychotic and mood stabilizer. While some states have begun to limit the quantity of DXM sold or restrict sales to individuals over 18-years of age, there is currently no federal ban or restriction on DXM. Abuse of DXM, a readily available and typically inexpensive agent that is not detected on a standard urine drug screen, may be an under-recognized cause of substance-induced psychosis. It is imperative that clinicians are aware of the potential psychiatric sequelae of recreational DXM use.

Entities:  

Keywords:  DXM; cold preparations; delusions; dextromethorphan; hallucinations; paranoia; phencyclidine; psychosis

Mesh:

Substances:

Year:  2017        PMID: 28936010      PMCID: PMC5601090     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  13 in total

1.  Advisers vote against declaring dextromethorphan a controlled substance.

Authors:  Kate Traynor
Journal:  Am J Health Syst Pharm       Date:  2010-11-01       Impact factor: 2.637

2.  Dextromethorphan abuse leading to assault, suicide, or homicide.

Authors:  Barry K Logan; Jillian K Yeakel; Gary Goldfogel; Michael P Frost; Greg Sandstrom; Dennis J Wickham
Journal:  J Forensic Sci       Date:  2012-04-26       Impact factor: 1.832

3.  A Case of Aggressive Psychosis in the Setting of Regular Dextromethorphan Abuse.

Authors:  Tyler Okland; Matthew Shirazi; Melanie Rylander; John Holland
Journal:  Psychosomatics       Date:  2016-06-11       Impact factor: 2.386

4.  Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors.

Authors:  K T LePage; J E Ishmael; C M Low; S F Traynelis; T F Murray
Journal:  Neuropharmacology       Date:  2005-04-01       Impact factor: 5.250

5.  Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center.

Authors:  S Banerji; I B Anderson
Journal:  Am J Health Syst Pharm       Date:  2001-10-01       Impact factor: 2.637

Review 6.  From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.

Authors:  Hamilton Morris; Jason Wallach
Journal:  Drug Test Anal       Date:  2014-03-26       Impact factor: 3.345

7.  Cough syrup psychosis.

Authors:  Alfred Amaladoss; Simon O'Brien
Journal:  CJEM       Date:  2011-01       Impact factor: 2.410

8.  Dextromethorphan psychosis, dependence and physical withdrawal.

Authors:  Shannon C Miller
Journal:  Addict Biol       Date:  2005-12       Impact factor: 4.280

9.  How often do false-positive phencyclidine urine screens occur with use of common medications?

Authors:  Arvind Rengarajan; Michael E Mullins
Journal:  Clin Toxicol (Phila)       Date:  2013-05-23       Impact factor: 4.467

Review 10.  Dextromethorphan. An overview of safety issues.

Authors:  J L Bem; R Peck
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

View more
  3 in total

1.  Modulatory Effects of Memantine on Neuronal Response Properties in Rat Barrel Cortex.

Authors:  Mahin Nasiri; Ayat Kaeidi; Iman Fatemi; Mahdieh Azin; Mahboobeh Bannazadeh; Mohammad Allahtavakoli; Ali Roohbakhsh; Ali Shamsizadeh
Journal:  Basic Clin Neurosci       Date:  2021-11-01

2.  A human stem cell-derived test system for agents modifying neuronal N-methyl-D-aspartate-type glutamate receptor Ca2+-signalling.

Authors:  Stefanie Klima; Markus Brüll; Anna-Sophie Spreng; Ilinca Suciu; Tjalda Falt; Jens C Schwamborn; Tanja Waldmann; Christiaan Karreman; Marcel Leist
Journal:  Arch Toxicol       Date:  2021-03-13       Impact factor: 5.153

3.  The Benzydamine Experience: A Systematic Review of Benzydamine Abuse.

Authors:  Chiappini Stefania; Miuli Andrea; Mosca Alessio; Pettorruso Mauro; Guirguis Amira; Corkery John Martin; Martinotti Giovanni; Schifano Fabrizio
Journal:  Curr Neuropharmacol       Date:  2021-10-18       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.